Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.

被引:0
|
作者
De Ledinghen, V
Trimoulet, P
Winnock, M
Bernard, PH
Bourliere, M
Portal, I
Remy, AJ
Canva, V
Levy, S
Foucher, J
Chene, G
Couzigou, P
机构
[1] Hop Haut Leveque, Pessac, France
[2] INSERM, U330, Bordeaux, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1655
引用
收藏
页码:586A / 586A
页数:1
相关论文
共 50 条
  • [1] Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C
    de Lédinghen, V
    Trimoulet, P
    Winnock, M
    Foucher, J
    Bourlière, M
    Desmorat, H
    Canva, V
    Capron, D
    Lévy, S
    Mion, F
    Mannant, PR
    Chêne, G
    Fleury, H
    Couzigou, P
    Bernard, PH
    JOURNAL OF HEPATOLOGY, 2002, 36 (05) : 672 - 680
  • [2] Daily or three times per week interferon α-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone
    de Lédinghen, V
    Trimoulet, P
    Winnock, M
    Bernard, PH
    Bourlière, M
    Portal, I
    Rémy, AJ
    Szostak, N
    Lévy, S
    Tran, A
    Abergel, A
    Chêne, G
    Fleury, H
    Couzigou, P
    JOURNAL OF HEPATOLOGY, 2002, 36 (06) : 819 - 826
  • [3] Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
    Davis, GL
    Esteban-Mur, R
    Rustgi, V
    Hoefs, J
    Gordon, SC
    Trepo, C
    Shiffman, ML
    Zeuzem, S
    Craxi, A
    Ling, MH
    Albrecht, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1493 - 1499
  • [4] Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
    McHutchison, JG
    Gordon, SC
    Schiff, ER
    Shiffman, ML
    Lee, WM
    Rustgi, VK
    Goodman, ZD
    Ling, MH
    Cort, S
    Albrecht, JK
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21): : 1485 - 1492
  • [5] Daily or three times a week interferon alfa2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C, final results of a randomized prospective study
    de Ledinghen, V
    Trimoulet, P
    Winnock, M
    Foucher, J
    Chene, G
    Couzigou, P
    Bernard, P
    JOURNAL OF HEPATOLOGY, 2001, 34 : 138 - 138
  • [6] Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patients
    Fabris, P
    Tositti, G
    Negro, F
    Marranconi, F
    Infantolino, D
    Rassu, M
    De Lalla, F
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (10) : 1329 - 1334
  • [7] A randomized 4-Arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone
    Saracco, G
    Ciancio, A
    Olivero, A
    Smedile, A
    Roffi, L
    Croce, G
    Colletta, C
    Cariti, G
    Andreoni, M
    Biglino, A
    Calleri, G
    Maggi, G
    Tappero, GF
    Orsi, PG
    Terreni, N
    Macor, A
    Di Napoli, A
    Rinaldi, E
    Ciccone, G
    Rizzetto, M
    HEPATOLOGY, 2001, 34 (01) : 133 - 138
  • [8] A randomised 4-arm multicentre study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone
    Saracco, G
    Ciancio, A
    Olivero, A
    Smedile, A
    Roffi, L
    Croce, G
    Colletta, C
    Cariti, G
    Andreoni, M
    Biglino, A
    Calleri, G
    Maggi, G
    Tappero, GF
    Orsi, PG
    Terreni, N
    Macor, A
    Di Napoli, A
    Rinaldi, E
    Ciccone, G
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 3 - 3
  • [9] Interferon-α alone versus interferon-α plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-α treatment
    Tripi, S
    Di Gaetano, G
    Soresi, M
    Cartabellotta, F
    Vassallo, R
    Carroccio, A
    Anastasi, G
    Montalto, G
    BIODRUGS, 2000, 13 (04) : 299 - 304
  • [10] Combination therapy with interferon and ribavirin for treatment of patients with chronic Hepatitis C who have failed therapy with interferon alone.
    Lynch, PJ
    Jacobsmeyer, S
    Quigley, M
    Peters, MG
    HEPATOLOGY, 1998, 28 (04) : 576A - 576A